Search Results 91-100 of 16526 for Glucocorticoids

  1. Role Of Phosphorus And FGF 23 In Patients With Dent Disease - Mayo Clinic

    glucocorticoids; or; estrogens within one month of the study. Exclusion criteria for calcium stone formers include: primary or secondary hyperparathyroidism ...

  2. Mayo Clinic Comprehensive Cancer Center — Research

    Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production. Rochester, Minn ...

  3. Granulomatous Vasculitis Clinical Trials - Mayo Clinic Research

    Multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of abatacept to achieve sustained glucocorticoid-free remission in ...

  4. Metyrapone for Mild Autonomous Cortisol Secretion - Mayo Clinic

    Planned use of oral exogenous glucocorticoid therapy. Planned use of opioid therapy > 20 MME/day. Use of injectable glucocorticoid within the last 6 weeks.

  5. A Study to Evaluate Abatacept to Treat Giant Cell Arteritis - Mayo Clinic

    All patients will receive glucocorticoids (GC) which will be tapered and discontinued by week 26 according to a standardized schedule. Patients who achieve ...

  6. Mayo Clinic: Add Bone Deterioration to Diabetes Complications

    ... glucocorticoids are used, such as in rheumatoid arthritis. The team says more research needs to be done, as this was a small study in a limited population ...

  7. Jun Liu, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    ... glucocorticoids for maintaining the whole-body energy balance. Significance to patient care. The ultimate goal of Dr. Liu's research is to discover new lipid ...

  8. Pemphigus - Symptoms and causes - Mayo Clinic

    Major side effects of systemic glucocorticoids. https://www.uptodate.com/contents/search. Accessed Sept. 19, 2018. Ferri FF. Pemphigus vulgaris. In: Ferri's ...

  9. Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia - Mayo Clinic

    or consumption of any material that interferes with the metabolism of glucocorticoids. - Participants on regular daily inhaled, topical, nasal, or oral ...

  10. Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy - Mayo Clinic

    The typical treatment for IIM is high-dose glucocorticoids combined with immunosuppressive drugs. Participation eligibility. Participant eligibility includes ...